Hepatic and biliary damage after transarterial chemoembolization for malignant hepatic tumors: Incidence, diagnosis, treatment, outcome and mechanism
Authors:
- Gaopeng LiGLGaopeng Li
- Xi AiXAXi Ai
- Baoming LuoBLBaoming Luo
- Yanling WenYWYanling Wen
- Zizhuo ZhaoZZZizhuo Zhao
- Shengli DongSDShengli Dong
- Jian GuanJGJian Guan
- 1 August 2011
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 79 (2) , 164-174
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Nonresectable Hepatocellular Carcinoma: Long-term Toxicity in Patients Treated with Transarterial Chemoembolization—Single-Center ExperienceRadiology, 2008
- Study of severe and rare complications of transarterial chemoembolization (TACE) for liver cancerEuropean Journal of Radiology, 2006
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalHepatology, 2003
- Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinomaHepatology, 2002
- Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialThe Lancet, 2002
- Transcatheter arterial embolization for advanced hepatocellular carcinoma: The controversy continuesHepatology, 1998
- Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization.Radiology, 1996
- Chemoembolisation with lipiodol and doxorubicin: applicability in British patients with hepatocellular carcinoma.Gut, 1996
- A Comparison of Lipiodol Chemoembolization and Conservative Treatment for Unresectable Hepatocellular CarcinomaNew England Journal of Medicine, 1995
- Changes in hepatic functional reserve after transcatheter embolization of hepatocellular carcinomaJournal of Hepatology, 1988